TNGX in the 13F filings
Tango Therapeutics Inc · CUSIP 87583X109
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 3 listed it in both
- Shares listed
- 39,515,991
- combined, among listed positions
- Reported value
- $350m
- combined, at the quarter end
Among the 92 comparable managers: 14 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +8,379,649.
Managers listing TNGX in Q4 2025
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Woodline Partners LPexisting position · 10,072,225 shares now+4,042,297
- Fidelity (FMR LLC)existing position · 2,867,548 shares now+2,861,122
- Farallon Capital Management LLCexisting position · 13,061,411 shares now+2,304,411
- Balyasny Asset Management LLCexisting position · 5,278,580 shares now+1,806,373
- D. E. Shaw & Co.existing position · 1,025,553 shares now+595,174
Reductions
- Marshall Wace LLPexisting position · 329,231 shares now-1,160,287
- Point72 Asset Management LPexisting position · 1,974,035 shares now-945,415
- Invesco Ltdexisting position · 177,610 shares now-854,307
- Millennium Management LLCexisting position · 593,004 shares now-702,397
- Voloridge Investment Management LLCexisting position · 255,127 shares now-129,080
New positions and exits
New (3)
Exited (2)
- Two Sigma Advisers LPwas $790k
- Renaissance Technologies LLCwas $465k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2021 | 2 | $10m | n.a. | n.a. |
| Q4 2021 | 2 | $8.8m | n.a. | n.a. |
| Q1 2022 | 2 | $6.1m | n.a. | n.a. |
| Q2 2022 | 2 | $3.6m | n.a. | n.a. |
| Q3 2022 | 2 | $2.9m | n.a. | n.a. |
| Q4 2022 | 2 | $4.6m | n.a. | n.a. |
| Q1 2023 | 1 | $1.4m | n.a. | n.a. |
| Q2 2023 | 1 | $875k | n.a. | n.a. |
| Q3 2023 | 1 | $2.8m | n.a. | n.a. |
| Q2 2024 | 1 | $3.0m | 1 | 0 |
| Q4 2024 | 1 | $12m | 1 | 0 |
| Q1 2025 | 1 | $6.3m | 1 | 0 |
| Q2 2025 | 2 | $78m | 2 | 0 |
| Q3 2025 | 3 | $166m | 3 | 0 |
| Q4 2025 | 3 | $252m | 14 | 10 |
| Q1 2026 | 5 | $570m | 14 | 13 |
| Q2 2026 | 5 | $805m | 16 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TNGX and LLY →TNGX and JNJ →TNGX and VRTX →Choose a stock to compare with TNGX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TNGX, latest filings →Back to the 13F Explorer →